HER2-Targeted Therapies Summit | June 23-24, 2021 | Virtual Event

Temas de la conferencia
Welcome to the Digital HER2-Targeted Therapies Summit 2021 - The First Conference Focused on Exploring New Frontiers of HER2 as a Pan-Tumor Target

HER2 expressing patients are experiencing drug resistance, suboptimal duration of response and refractory/relapsed disease, stimulating new frontiers for HER2-targeted drug development. Impressive clinical data are being reported for next-generation anti-HER2 approaches in breast, gastric, lung, colon cancers and beyond.

Organizador profesional (PCO)
Hanson Wade

Observaciones
Brochure: https://go.evvnt.com/732396-3?pid=4832

https://go.evvnt.com/732396-0?pid=4832

Ms. Patrycja Kruk